MALACRIDA, ALESSIO
 Distribuzione geografica
Continente #
NA - Nord America 7.505
AS - Asia 7.448
EU - Europa 3.321
SA - Sud America 638
Continente sconosciuto - Info sul continente non disponibili 582
AF - Africa 116
OC - Oceania 17
Totale 19.627
Nazione #
US - Stati Uniti d'America 7.156
VN - Vietnam 3.748
SG - Singapore 1.429
IT - Italia 1.149
CN - Cina 879
HK - Hong Kong 513
DE - Germania 509
BR - Brasile 496
RU - Federazione Russa 414
CA - Canada 255
SE - Svezia 224
GB - Regno Unito 196
IN - India 167
KR - Corea 144
IE - Irlanda 133
FR - Francia 132
ID - Indonesia 108
AT - Austria 100
BD - Bangladesh 100
FI - Finlandia 70
UA - Ucraina 65
LT - Lituania 53
JP - Giappone 51
MX - Messico 47
AR - Argentina 46
ES - Italia 46
DK - Danimarca 45
IQ - Iraq 41
NL - Olanda 40
TR - Turchia 39
SA - Arabia Saudita 38
PL - Polonia 36
TW - Taiwan 36
ZA - Sudafrica 36
BE - Belgio 30
PK - Pakistan 26
EC - Ecuador 23
CH - Svizzera 21
CO - Colombia 20
PH - Filippine 20
VE - Venezuela 20
AU - Australia 16
MA - Marocco 16
MY - Malesia 16
CZ - Repubblica Ceca 15
AE - Emirati Arabi Uniti 14
EG - Egitto 13
JM - Giamaica 13
KE - Kenya 13
UZ - Uzbekistan 12
RO - Romania 11
PY - Paraguay 10
TN - Tunisia 10
CL - Cile 9
CR - Costa Rica 9
KZ - Kazakistan 8
AZ - Azerbaigian 7
GR - Grecia 7
HN - Honduras 6
NP - Nepal 6
RS - Serbia 6
BG - Bulgaria 5
OM - Oman 5
PE - Perù 5
TH - Thailandia 5
AM - Armenia 4
AO - Angola 4
BH - Bahrain 4
BO - Bolivia 4
ET - Etiopia 4
EU - Europa 4
PR - Porto Rico 4
UG - Uganda 4
UY - Uruguay 4
CY - Cipro 3
GT - Guatemala 3
IL - Israele 3
IR - Iran 3
JO - Giordania 3
KG - Kirghizistan 3
PA - Panama 3
PT - Portogallo 3
AL - Albania 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GE - Georgia 2
HU - Ungheria 2
LK - Sri Lanka 2
LY - Libia 2
NG - Nigeria 2
NI - Nicaragua 2
PS - Palestinian Territory 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
Totale 19.030
Città #
Ann Arbor 1.168
Ho Chi Minh City 1.167
Hanoi 953
Singapore 843
Dallas 839
San Jose 760
Ashburn 636
Hong Kong 500
Milan 402
Frankfurt am Main 365
Council Bluffs 201
Wilmington 198
Los Angeles 185
Chandler 154
Beijing 151
New York 148
Santa Clara 143
Toronto 141
Dublin 132
Hefei 131
Fairfield 128
Haiphong 116
Boardman 111
Columbus 111
Chicago 103
Seoul 98
Biên Hòa 92
Da Nang 90
Ha Long 90
Vienna 83
Woodbridge 78
Houston 76
Hải Dương 75
Quận Bình Thạnh 75
Jakarta 71
Rome 69
Dearborn 67
Buffalo 64
Princeton 58
Ninh Bình 56
The Dalles 54
Thái Nguyên 53
São Paulo 51
Lauterbourg 49
Can Tho 48
Vũng Tàu 47
Seattle 46
Shanghai 44
Quận Một 43
Bắc Giang 42
Jacksonville 42
Bắc Ninh 41
Cambridge 40
Munich 39
London 37
Quận Phú Nhuận 37
Moscow 36
Vilnius 36
Helsinki 35
Orem 35
Montreal 34
Phoenix 34
Chennai 33
Phủ Lý 32
Warsaw 32
Tokyo 30
Quận Sáu 29
Brooklyn 27
Pune 27
Turin 27
Nanjing 25
Điện Bàn 25
Boston 23
Kaohsiung 22
Nuremberg 22
Quảng Ninh 22
Kent 21
Vinh 21
Quận Bảy 20
Appiano Gentile 19
Lang Son 19
Poplar 19
Rio de Janeiro 19
San Diego 19
Stockholm 19
Lawrence 18
Brasília 17
Brussels 17
Denver 17
Johannesburg 17
Manchester 17
Mexico City 17
Thu Dau Mot 17
Zurich 17
Atlanta 16
Florence 16
Lappeenranta 16
Thái Bình 16
Lissone 15
Pavia 15
Totale 12.651
Nome #
Histone Deacetylase 6 Inhibitors: Mitigators Of Chemotherapy Induced Peripheral Neuropathy Via The NMNAT2/SARM1 Pathway Modulation 1.168
Evaluation of Histone Deacetylase 6 inhibitors as possible neuroprotectors against Paclitaxel-induced peripheral neurotoxicity 779
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 651
Sodium-Calcium Exchanger 2 Role In An In Vitro Oxaliplatin-Induced Peripheral Neurotoxicity Model 637
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 576
SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY 519
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 507
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 471
Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells 459
EVALUATION OF ANTITUMORAL EFFECTS OF HIBISCUS SABDARIFFA ON MULTIPLE MYELOMA CELLS 453
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa 421
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 415
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 411
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 396
Microtubule stabilisation and mitochondrial dysfunctions as axonal degeneration mechanisms in bortezomib-treated sensory neurons 390
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 367
Oxaliplatin-induced Peripheral Neurotoxicity: role of ion channels/transporters in axonal damage. 360
Proteasome inhibitors-based chemotherapy induced neurotoxicity: focus on cytoskeleton and mitochondrial dysfunction 356
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents 339
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 337
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 333
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents 331
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 330
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 327
Chemotherapy-induced peripheral neuropathy and changes in cytoskeleton 314
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 308
Evaluation of in vitro antitumoral activity and neurotoxicity of a Hibiscus Sabdariffa ethyl acetate fraction against human multiple myeloma cells 307
In vitro morphological study of bortezomib-induced peripheral neurotoxicity 301
Neurodegeneration: can metabolites from Eremurus persicus help? 297
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 297
The Role of NMNAT2/SARM1 in Neuropathy Development 295
Are sigma receptor modulators a weapon against multiple sclerosis disease? 294
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 291
Evaluation of antitumoral effect of Hibiscus sabdariffa extract on human breast cancer cells 290
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 282
Antitumoral effects of Hibiscus Sabdarifa on human oral squamous cell carcinoma and multiple myeloma cells 281
Topiramate in Oxaliplatin-Induced Peripheral Neurotoxicity: more than neuroprotection. 274
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 268
Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent 264
Anti-proliferative and anti-migratory effects of baicalin on cholangiocarcinoma cell line egi-1 263
PROTEASOME INHIBITORS: IN VITRO MORPHO- FUNCTIONAL CHANGES 262
RICOLINOSTAT INDUCES MICROTUBULE ACETYLATION AND NEURITE REGENERATION IN CELLULAR MODELS OF CHEMOTHERAPY-INDUCED NEUROPATHY 260
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 254
Rigosertib and cholangiocarcinoma: A cell cycle affair 247
In vitro evaluation of rigosertib antitumoral and radiosensitizing effects against human cholangiocarcinoma cells 244
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 243
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 226
From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells 225
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 219
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 205
SARM1 modulation by HDAC6 inhibition as a neuroprotective strategy in chemotherapy-induced peripheral neuropathy 201
Unravelling axonal damage mechanisms in peripheral nerves: the role of sodium-calcium (NCX) exchanger 176
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa—part 2 163
Protective effect of new histone deacetylase 6 inhibitors in a cisplatin-induced peripheral neurotoxicity murine model 125
Molecular Mechanisms of Proteasome Inhibitor-Induced Peripheral Neuropathy 121
Recent advances in the discovery of ALKBH 1–8 inhibitors 86
Shared and specific molecular mechanisms of proteasome inhibitors in chemotherapy-induced peripheral neurotoxicity 80
Proteasome inhibitors-based chemotherapy-induced neurotoxicity: mitochondrial, calcium signalling and cytoskeleton alterations 71
MECHANISTIC IMPLICATIONS OF TUBULIN POST- TRANSLATIONAL MODIFICATIONS IN A PRECLINICAL MODEL OF PROTEASOME INHIBITOR- INDUCED PERIPHERAL NEUROPATHY 61
Role of the Sodium–Calcium Exchanger NCX2 in Oxaliplatin-Induced Peripheral Neurotoxicity 50
From lichen to organoids: Usnic acid enantiomers show promise against Cholangiocarcinoma via MNK2 targeting and MAPK pathway modulation 37
Electrophysiological mechanisms behind the differential cardiotoxicity of chemotherapeutic agents Bortezomib and Carfilzomib 35
Design and Biological Evaluation of ALKBH2 and ALKBH5 Inhibitors as Adjuvants to Temozolomide-Based Glioblastoma Treatment 34
Sodium-Calcium Exchanger NCX2 Role in Oxaliplatin Induced Peripheral Neurotoxicity Development 27
NCX2 Targeting as a Neuroprotective Strategy Against Oxaliplatin-Induced Peripheral Neurotoxicity 16
Totale 19.627
Categoria #
all - tutte 52.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022488 0 0 77 53 42 56 30 30 20 25 50 105
2022/20231.012 94 221 158 88 80 121 31 63 55 21 52 28
2023/2024668 24 23 31 23 65 138 91 37 48 21 7 160
2024/20252.793 183 175 189 134 263 180 188 90 296 362 238 495
2025/202610.838 3.240 1.378 1.108 785 632 355 1.020 314 495 618 414 479
2026/20271.329 438 418 473 0 0 0 0 0 0 0 0 0
Totale 19.627